What Northwest Technology Ventures does

Northwest Technology Ventures (NTV) is a formation-stage venture capital fund based in Portland, Oregon, that undertakes seed and early-stage investments in technology and life sciences companies originating from the state's public and private universities, research institutions, and corporate research laboratories. Founded in 2005 with a $14 million fund, NTV is explicitly structured to bridge the "capital gap" between conventional early-stage venture capital and research-stage discoveries — situations where technology exists but the underlying business is not yet defined. The firm provides not only capital but hands-on management assistance and business development support to help founders shape investable opportunities around available technology.

The fund's portfolio spans multiple deep-technology verticals. Semiconductor exposure includes Translarity (formerly Advanced Inquiry Systems, wafer test for flash/DRAM/logic) and BeSang (proprietary 3D integrated circuit technology targeting image sensor and memory markets). Software and data exposure includes Adapx's Capturx (digital pen software integrating handwriting into Microsoft Office and GIS/CAD systems), Attensa (cloud-based information aggregation), AboutUs (wiki platform), and Clinicient (outpatient rehabilitation clinic systems). Renewable energy exposure comes via Perpetua's flexible thermoelectric film for wireless sensors, with the wearables line spun out into Theramgen in 2014. Life sciences exposure includes Artielle ImmunoTherapeutics (RTL1000 for multiple sclerosis, Phase 1 trials with FDA Orphan Drug status), DesignMedix (revoquine anti-malarial compounds), Virogenomics (viral disease drug discovery platform developed at OHSU), and Floragenex (RAD-based genetic sequencing services). Portfolio companies have collectively raised more than $225 million in outside equity investment and over $35 million in non-equity grants and contracts.

The fund operates with a lean team: two Managing Directors — William Newman and Gordon Hoffman — supported by Candace Clement, contracted outside advisors for diligence and team-building, and a Board of Advisors providing business, financial, technology, and institutional expertise. Revenue is generated through equity returns from portfolio exits (acquisitions, mergers, IPOs) and, to a lesser extent, fund management economics. Notable realizations include Vigilan's acquisition by RealPage in 2011, Perpetua's wearables spin-off into Theramgen in 2014, and AboutUs's merger with Attensa in 2015. As of the most recent disclosure, the fund is fully committed and operating in portfolio-management mode, with no new investment activity and active support of portfolio companies pursuing follow-on capital and liquidity events.

Name

Northwest Technology Ventures

Legal name

Northwest Technology Ventures

Website

https://nwtechventures.com

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

1–10 employees

Short description

Northwest Technology Ventures is a Portland, Oregon-based formation-stage venture capital fund that makes seed and early-stage investments in technology and life sciences companies emerging from Oregon universities and research institutions.

Ownership category

akta.pro rank

Product category

Venture Capital

NAICS

Other Investment Pools and Funds (5259)

SIC

Investment Advice (6282)

akta.pro primary industry

Early-Stage Venture Capital (Pre-Seed/Seed) (FSANAAAA)

akta.pro secondary industry

Geography-Focused Venture Capital (Regional/Emerging Markets) (FSANAAAE)

Keywords

• Seed venture capital
• Early-stage investing
• Technology commercialization
• Life sciences funding
• Oregon startup capital

Headquarters

HQ city

Beaverton

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Venture Capital Returns: NTV generates returns through equity investments in seed and early-stage companies. The fund earns returns when portfolio companies achieve successful exits through acquisition, IPO, or other liquidity events. Currently fully committed with an existing portfolio of companies.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

Northwest Technology Ventures is a formation-stage venture capital fund that provides seed and early-stage capital to technology and life sciences companies emerging from Oregon's universities, research institutions, and corporate research laboratories. The firm bridges the gap between conventional early-stage venture funds and the commercialization of research discoveries, supplementing capital investment with management assistance.

Product overview

Northwest Technology Ventures is a formation-stage venture fund, not a product company. It does not offer a unified platform or product suite. NTV's investment activity encompasses portfolio companies operating across technology and life sciences sectors, including software products (Capturx, Attensa, Clinicient), semiconductor technologies (Translarity, BeSang), renewable energy solutions (Perpetua), drug development programs (RTL1000, DesignMedix, Virogenomics), and genetic research services (Floragenex). These are distinct portfolio company offerings, not NTV-branded products.

Differentiator

Problem solved

Functional benefit

Products and services

• Northwest Technology Ventures Seed and Early-Stage Fund

Quantifiable outcome

• Portfolio companies have raised over $225 million in outside investment
• +1 more outcomes

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

Partnerships

One partnership is on record.

• Oregon Universities and Research InstitutionscoreStrategic or Co-development PartnerNTV's core partnership network includes Oregon's public and private universities, research institutions, and corporate research laboratories. These institutions provide the deal flow and technology pipeline that NTV invests in, representing the fund's primary sourcing channel for investment opportunities.

Scale indicators4 records

Recent moves5 records

Expansion highlights3 records

Broad incumbents

• Y Combinator: Largest global pre-seed/seed accelerator; broad incumbent providing standardized seed funding and mentorship that competing regional seed funds like NTV either complement or compete against for the same early founders.
• ARCH Venture Partners: Large US venture firm that originated from university research; a much larger incumbent version of NTV's research-commercialization thesis, particularly in biotech, semiconductors, and advanced technology.
• Techstars: Global accelerator with broad-based early-stage programs; comparable to NTV at the seed stage but at much greater scale, competing for the same pool of Oregon-sourced technology startups.

Direct peers

• Portland Seed Fund: Portland-based seed-stage VC investing in Oregon and SW Washington startups; closest direct peer to NTV given shared regional focus, seed-stage mandate, and similar early-stage technology/life sciences portfolio orientation.
• Oregon Venture Fund (formerly OVP): Oregon-focused early-stage venture firm backing technology and life sciences companies sourced from regional universities and startups; essentially the same investment geography and stage as NTV.
• Elevate Capital: Pacific Northwest-based seed fund investing in Oregon and SW Washington startups across tech and life sciences; closely comparable regional seed mandate and sector mix.
• Keiretsu Forum Portland Chapter: Angel investor network with an active Portland chapter that invests in Pacific Northwest early-stage companies; comparable regional seed/early-stage deal flow, especially for technology and life sciences.
• SeaChange Fund: Pacific Northwest early-stage VC targeting technology and life sciences opportunities, with similar thesis of bridging research and commercialization; comparable to NTV's geography and pre-seed/seed thesis.
• Seven Peaks Ventures: Oregon-based early-stage VC investing in Pacific Northwest B2B software and tech companies; comparable regional and stage focus with strong emphasis on supporting founders from research and corporate backgrounds.

Regional players

• CTI Bioventures (now Bio): Formerly CTI Bioventures, a Pacific Northwest life sciences focused investment firm that historically partnered with research institutions; relevant peer for NTV's life sciences portfolio orientation within Oregon/Washington.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments9 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Northwest Technology Ventures